Danaher Corporation (NYSE:DHR) is one of the best medical stocks to buy now. On September 22, BofA lowered the firm’s price target on Danaher Corporation (NYSE:DHR) to $220 from $230 while keeping a Buy rating on the shares. Danaher Corporation (DHR) Is "Fool's Gold," Bemoans Jim Cramer The firm told investors that although some trends are showing stabilization and/or improvement in certain areas of Life Sciences and Diagnostic Tools, there exist several pockets of uncertainty and softness over the past ...